EP1814608 - MEDICAL DEVICES CONTAINING RAPAMYCIN ANALOGS [Right-click to bookmark this link] | Status | The application has been refused Status updated on 27.01.2012 Database last updated on 31.08.2024 | Most recent event Tooltip | 27.01.2012 | Refusal of application | published on 29.02.2012 [2012/09] | Applicant(s) | For all designated states ABBOTT LABORATORIES 100 Abbott Park Road Abbott Park, IL 60064-3500 / US | [N/P] |
Former [2008/36] | For all designated states ABBOTT LABORATORIES CHAD 0377/AP6A-1 100 Abbott Park Road Abbott Park IL 60064-3500 / US | ||
Former [2007/32] | For all designated states ABBOTT LABORATORIES Dept. 377, Bldg AP6A-1, 100 Abbott Park Road Abbott Park, IL 60064-6060 / US | Inventor(s) | 01 /
MOLLISON, Karl, W. 4020 North Harvard Ave. Arlington Heights, IL 60004 / US | 02 /
LECAPTAIN, Angela, M. 555 E. Bridlewood Lane Oak Creek, WI 53154 / US | 03 /
BURKE, Sandra, E. 1025 Regency Lane Libertyville, IL 60048 / US | 04 /
CROMACK, Keith, R. 18066 W. Banbury Gurnee, IL 60031 / US | 05 /
TARCHA, Peter, J. 21651 Gelden Road Lake Villa, IL 60046 / US | [2007/32] | Representative(s) | Keen, Celia Mary J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB | [N/P] |
Former [2007/32] | Keen, Celia Mary J.A. Kemp & Co. 14 South Square Gray's Inn London WC1R 5JJ / GB | Application number, filing date | 05820209.4 | 28.10.2005 | [2007/32] | WO2005US39097 | Priority number, date | US20040977288 | 29.10.2004 Original published format: US 977288 | [2007/32] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2006050170 | Date: | 11.05.2006 | Language: | EN | [2006/19] | Type: | A2 Application without search report | No.: | EP1814608 | Date: | 08.08.2007 | Language: | EN | The application published by WIPO in one of the EPO official languages on 11.05.2006 takes the place of the publication of the European patent application. | [2007/32] | Search report(s) | International search report - published on: | EP | 12.07.2007 | Classification | IPC: | A61L31/16, A61L29/16, A61K31/7048, A61P9/10 | [2007/32] | CPC: |
A61K31/7048 (EP,US);
A61L27/34 (EP,US);
A61L27/54 (EP,US);
A61L29/085 (EP,US);
A61L29/16 (EP,US);
A61L31/10 (EP,US);
A61L31/16 (EP,US);
A61P9/00 (EP);
A61P9/10 (EP);
C07D498/18 (EP,US);
A61L2300/216 (EP,US);
A61L2300/41 (EP,US);
A61L2300/416 (EP,US);
A61L2300/42 (EP,US);
A61L2300/43 (EP,US);
A61L2300/45 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2007/32] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | MK | Not yet paid | YU | Not yet paid | Title | German: | MEDIZINISCHE GERÄTE, DIE RAPAMYCINANALOGA ENTHALTEN | [2007/32] | English: | MEDICAL DEVICES CONTAINING RAPAMYCIN ANALOGS | [2007/32] | French: | DISPOSITIFS MEDICAUX CONTENANT DES ANALOGUES DE RAPAMYCINE | [2007/32] | Entry into regional phase | 21.05.2007 | National basic fee paid | 21.05.2007 | Designation fee(s) paid | 21.05.2007 | Examination fee paid | Examination procedure | 21.05.2007 | Amendment by applicant (claims and/or description) | 21.05.2007 | Examination requested [2007/32] | 26.03.2008 | Despatch of a communication from the examining division (Time limit: M04) | 31.07.2008 | Reply to a communication from the examining division | 18.05.2011 | Application refused, date of legal effect [2012/09] | 18.05.2011 | Date of oral proceedings | 14.06.2011 | Despatch of communication that the application is refused, reason: substantive examination [2012/09] | 14.06.2011 | Minutes of oral proceedings despatched | Divisional application(s) | EP10012118.5 / EP2277565 | EP10012119.3 / EP2277566 | EP10012120.1 / EP2277567 | EP10012121.9 / EP2277568 | EP10012122.7 / EP2277569 | EP10012123.5 / EP2277570 | EP10012124.3 / EP2292280 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 26.03.2008 | Fees paid | Renewal fee | 21.02.2008 | Renewal fee patent year 03 | 27.03.2008 | Renewal fee patent year 04 | 07.10.2009 | Renewal fee patent year 05 | 23.09.2010 | Renewal fee patent year 06 | 10.10.2011 | Renewal fee patent year 07 | Penalty fee | Additional fee for renewal fee | 31.10.2007 | 03   M06   Fee paid on   21.02.2008 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]US5288711 (MITCHELL ROBERT D [US], et al) [X] 1-3,7-14,18-23 * column 2, line 44 * * column 7, line 16 - line 20 *; | [X]US5646160 (MORRIS RANDALL ELLIS [US], et al) [X] 1-3,7-14,18-23 * claims 1-3 * * column 4, line 12 - line 16 *; | [X]WO0187375 (CORDIS CORP [US]) [X] 1-3,7-14,18-23 * claims 1-5,17-24 *; | [X]US2003129215 (MOLLISON KARL W [US], et al) [X] 1-3,7-14,18-23* claims 1,2 *; | [X]US6641611 (JAYARAMAN SWAMINATHAN [US]) [X] 1-3,7-14,18-23 * claims 1-4 * * column 10, line 47 - column 11, line 40 *; | [X]US6726923 (IYER SRIRAM S [US], et al) [X] 1-3,7-14,18-23 * claims 1,15,16 *; | [X]WO2004060283 (NITROMED INC [US], et al) [X] 1,7,18 * claims 67,68,79,86,87 * * page 40, line 11 - line 14 * * page 25, paragraph 3 *; | [PX]WO2004098495 (UNIV COLUMBIA [US]) [PX] 1-3,7-14,18-23 * claims 1-6 *; | [PX]EP1550472 (CORDIS CORP [US]) [PX] 1-3,7-14,18-23 * claims 2-5,8 * * paragraphs [0042] , [0116] , [0246] *; | [A] - GREGORY C R ET AL, "TREATMENT WITH RAPAMYCIN AND MYCOPHENOLIC ACID REDUCES ARTERIAL INTIMAL THICKENING PRODUCED BY MECHANICAL INJURY AND ALLOWS ENDOTHELIAL REPLACEMENT", TRANSPLANTATION, WILLIAMS AND WILKINS, BALTIMORE, MD, US, (19950315), vol. 59, no. 5, ISSN 0041-1337, pages 655 - 661, XP000569311 [A] * page 655, column 2, paragraph 2 * | by applicant | - "Efficacy Evaluation of a Rapamycin Analog (A-179578) Delivered from the Biocompatibles BiodivYsio PC Coronary Stents in Porcine Coronary Arteries", SCHWARTZ, R.S., Technical Report, MAYO CLINIC AND FOUNDATION | - GREGORY, C., SUMMARY OF STUDY EVALUATING EFFECTS OF ABT-578 IN A RAT MODEL OF VASCULAR INJURY |